ABC | Volume 112, Nº5, May 2019

Updated Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology – 2019 Arq Bras Cardiol. 2019; 112(5):649-705 206. Barbosa PJ, Müller RE, Latado AL, Achutti AC, Ramos AI, Weksler C et al. Diretrizes Brasileiras para Diagnóstico, Tratamento e Prevenção da Febre Reumática da Sociedade Brasileira deCardiologia, da Sociedade Brasileira de Pediatria e da Sociedade Brasileira de Reumatologia. Arq Bras Cardiol. 2009;93(3 supl.4):1-18. 207. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the managementof infectiveendocarditis:TheTaskForce fortheManagement of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. 208. Monmeneu Menadas JV, Marín Ortuño F, Reyes Gomis F, Jordán Torrent A, García Martínez M, Bodí Peris V et al. Betablockade and exercise capacity in patients withmitral stenosis in sinus rhythm. J Heart Valve Dis. 2002;11(2):199-203. 209. TeresaE.Tratamientodiuréticode la insuficienciacardíaca.RevEspCardiol Supl. 2007;7:34F-44F. 210. Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-ZeitounD et al. Late results of percutaneous mitral commissurotomy up to 20 years development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation. 2012;125(17):2119-27. 211. Wilkins GT,Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299-308. 212. Chmielak Z, Klopotowski M, DemokowM, Konka M, Hoffman P, Kukuła K et al. Percutaneous mitral balloon valvuloplasty beyond 65 years of age. Cardiol J. 2013;20(1):44-51. 213. Sud K, Agarwal S, Parashar A, RazaMQ, Patel K, MinDet al. Degenerative mitral stenosis unmet need for percutaneous interventions. Circulation. 2016;133(16):1594-604. 214. Guerrero M, Dvir D, Himbert D, Urena M, Eleid M et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the First Multicenter Global Registry. JACC Cardiovasc Interv. 2016;9(13):136-71. 215. Singh JP, Evans JC, LevyD, LarsonMG, Freed LA, Fuller DL et al. Prevalence and clinical determinants of mitral, tricuspid and aortic regurgitation (The Framingham Heart Study). Am J Cardiol. 1999;83(6):897-902. Erratum in: Am J Cardiol. 1999;84(9):1143. 216. Bell MH, Mintz GS. Mitral valve disease in the elderly. Cardiovasc Clin. 1986;16(2):313-24. 217. Huep JC, Gonçalves RS, Ferreira RM. A importância do eletrocardiograma, daradiografiadetóraxedostestesdecapacidadefuncionalnaavaliaçãodas valvopatiasmitrais. Rev Soc Cardiol Estado São Paulo. 2008;18(4):319-27. 218. RossiEG. Insuficiênciamitral. In:GrinbergM,SampaioRO.DoençaValvar. São Paulo: Manole; 2006. 219. Moffa PJ, Sanches PCR, Uchida A. Eletrocardiologia: utilidade do eletrocardiograma em repouso. In: Grinberg M, Sampaio RO. Doença Valvar. São Paulo: Manole; 2006. 220. Lucarelli C. Radiologia convencional. In: Grimberg M, Sampaio RO. Doença Valvar. São Paulo: Manole; 2006. 221. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H et al.; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451-96. 222. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA et al.; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for theManagement of PatientsWith Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on PracticeGuidelines. Circulation. 2014;129(23):e521-643. Erratum in: Circulation. 2014;130(13):e120. Circulation. 2014;129(23):e651. 223. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. ACC/AHA 2006 guidelines for themanagement of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48(3):e1- 148. Erratum in: J Am Coll Cardiol. 2007;49(9):1014. 224. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation. 2003;108(20):2432-8. 225. Sampaio RO, Grinberg M, Leite JJ, Tarasoutchi F, Chalela WA, Izaki M et al. Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease. Am J Cardiol. 2005;96(1):117-21. 226. Reuter S, Garrigue S, Barold SS, Jais P, Hocini M, Haissaguerre M et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol. 2002;89(3):346-50. 227. Lazam S, Vanoverschelde JL, Tribouilloy C, Grigioni F, Suri RM, Avierinos JF et al.; MIDA (Mitral Regurgitation International Database) Investigators. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry. Circulation. 2017;135(5):410-22. 228. Prendergast BD, De Bonis M. Valve repair: a durable surgical option in degenerative mitral regurgitation. Circulation. 2017;135(5):423-5. 229. Muller DW, Farivar RS, Jansz P, Bae R, Walters D, Clarke A et al.; Tendyne Global Feasibility Trial Investigators. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation. J AmColl Cardiol. 2017;69(4):381-91. 230. Edwards FH, Cohen DJ, O'Brien SM, Peterson ED, MackMJ, Shahian DM et al.; Steering Committee of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol. 2016;1(1):46-52. 231. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35(5):526-9. 232. Enriquez-SaranoM, Tajik AJ. Clinical practice: aortic regurgitation. N Engl J Med. 2004;351(15):1539-46. 233. Gaasch WH, Sundaram M, Meyer TE. Managing asymptomatic patients with chronic aortic regurgitation. Chest. 1997;111(6):1702-9. 234. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991;84(4):1625-35. 235. Lancelotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P et al. ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34(21):1597-606. 236. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-termvasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005;353(13):1342-9. 237. de Meester C, Pasquet A, Gerber BL, Vancraeynest D, Noirhomme P, El Khoury G et al. Valve repair improves the outcome of surgery for chronic 701